Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 30,763 articles published since 2009
|||| 45 

These are the 30763 published articles about Pancreatic Neoplasms that originated from Worldwide during 2009-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
126 Editorial Treating pancreatic cancer: more antioxidants more problems? 2018

Alexander, Matthew S / Cullen, Joseph J. ·a Departments of Surgery and Radiation Oncology, Holden Comprehensive Cancer Center , The University of Iowa Hospitals and Clinics and the University of Iowa College of Medicine , Iowa City , IA , USA. ·Expert Rev Gastroenterol Hepatol · Pubmed #29956580.

ABSTRACT: -- No abstract --

127 Editorial Pancreatic cysts: Is the answer on the wall? 2018

Nakai, Yousuke / Koike, Kazuhiko. ·Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. ·Dig Endosc · Pubmed #29947440.

ABSTRACT: -- No abstract --

128 Editorial Germline Genetic Testing for Pancreatic Ductal Adenocarcinoma at Time of Diagnosis. 2018

Syngal, Sapna / Furniss, C Sloane. ·Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. · Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts. ·JAMA · Pubmed #29922810.

ABSTRACT: -- No abstract --

129 Editorial Unmasking Pancreatic Cancer: Epitope Spreading After Single Antigen Chimeric Antigen Receptor T-Cell Therapy in a Human Phase I Trial. 2018

Heckler, Max / Dougan, Stephanie K. ·Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Electronic address: Stephanie_Dougan@dfci.harvard.edu. ·Gastroenterology · Pubmed #29885301.

ABSTRACT: -- No abstract --

130 Editorial A new three-step procedure for pancreatic head carcinoma with invasion of superior mesenteric artery. 2018

Tang, Rui / Dong, Jia-Hong. ·Department of Hepatopancreatobiliary Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, No.168 Litang Road, Changping District, Beijing 102218, China. · Department of Hepatopancreatobiliary Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, No.168 Litang Road, Changping District, Beijing 102218, China. Electronic address: dongjiahong@mail.tsinghua.edu.cn. ·Hepatobiliary Pancreat Dis Int · Pubmed #29805086.

ABSTRACT: -- No abstract --

131 Editorial CT and MRI of pancreatic cancer: there is no rose without a thorn! 2018

Kartalis, N. ·Division of Radiology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden. nikolaos.kartalis@sll.se. · Department of Abdominal Radiology, Karolinska University Hospital, Stockholm, Sweden. nikolaos.kartalis@sll.se. ·Eur Radiol · Pubmed #29796919.

ABSTRACT: -- No abstract --

132 Editorial Pancreatic cancer screening in high-risk individuals: Ready for prime time? 2018

Bruno, Marco J. ·Department of Gastroenterology and Hepatology, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands. ·Gastrointest Endosc · Pubmed #29759159.

ABSTRACT: -- No abstract --

133 Editorial EUS-FNA giving way to fine-needle biopsy: Is it time to retire your old trusted needles? 2018

El Hajj, Ihab I / Al-Haddad, Mohammad. ·Division of Gastroenterology and Hepatology, Section of Interventional Endoscopy, Indiana University School of Medicine, Indianapolis, Indiana, USA. ·Gastrointest Endosc · Pubmed #29759158.

ABSTRACT: -- No abstract --

134 Editorial The Bleeding Risk after Endoscopic Ultrasound-Guided Fine Needle Aspiration in Patients Taking Antithrombotic Agents Is Not Negligible. 2018

Jang, Dong Kee / Lee, Sang Hyub. ·Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea. · Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. ·Gut Liver · Pubmed #29724088.

ABSTRACT: -- No abstract --

135 Editorial Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy. 2018

Cho, Chang Min. ·Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea. ·Gut Liver · Pubmed #29724087.

ABSTRACT: -- No abstract --

136 Editorial Mahvash Disease: 10 Years After Discovery. 2018

Yu, Run. ·From the Division of Endocrinology, Diabetes, and Metabolism, David Geffen School of Medicine at UCLA, Los Angeles, CA. ·Pancreas · Pubmed #29702528.

ABSTRACT: -- No abstract --

137 Editorial What is the Incidence of Malignancy in Resected IPMN? An Analysis of Over 100 U.S. Institutions in a Single Year. 2018

Schmidt, Carl R / Cloyd, Jordan. ·Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. carl.schmidt@osumc.edu. · Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. ·Ann Surg Oncol · Pubmed #29675763.

ABSTRACT: -- No abstract --

138 Editorial Preoperative biliary drainage in pancreatic head cancer patients. 2018

Aljahdli, Emad S. ·Division of Gastroenterology and Hepatology, Department of Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia. ·Saudi J Gastroenterol · Pubmed #29652035.

ABSTRACT: -- No abstract --

139 Editorial Management of distal malignant biliary obstruction. 2018

Aljahdli, Emad S. ·Consultant, Division of Gastroenterology, Department of Internal Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia. ·Saudi J Gastroenterol · Pubmed #29637911.

ABSTRACT: -- No abstract --

140 Editorial Novel Mechanism of Cancer Thrombosis Induced by Microvesicles. 2018

McCrae, Keith R. ·From the Taussig Cancer Institute and Department of Cellular and Molecular Medicine, Cleveland Clinic, OH. mccraek@ccf.org. ·Arterioscler Thromb Vasc Biol · Pubmed #29563113.

ABSTRACT: -- No abstract --

141 Editorial PAK4 pathway as a potential therapeutic target in pancreatic cancer. 2018

Thillai, Kiruthikah / Sarker, Debashis / Wells, Claire. ·Cancer Studies, King's College London, London, SE1 9RT, UK. · Department of Medical Oncology, Guy's & St Thomas' NHS Trust, London, SE1 9RT, UK. ·Future Oncol · Pubmed #29508632.

ABSTRACT: -- No abstract --

142 Editorial Early Detection of Pancreatic Cancer: The Role of Depression and Anxiety as a Precursor for Disease. 2018

Kenner, Barbara J. ·From the Kenner Family Research Fund, New York, NY. ·Pancreas · Pubmed #29498966.

ABSTRACT: -- No abstract --

143 Editorial Elucidating the link between collagen and pancreatic cancer: what's next? 2018

Hamada, Shin / Masamune, Atsushi. ·a Division of Gastroenterology , Tohoku University Graduate School of Medicine , Sendai , Japan. ·Expert Rev Gastroenterol Hepatol · Pubmed #29495889.

ABSTRACT: -- No abstract --

144 Editorial Editorial: peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms. 2018

Pommier, Rodney F. ·Division of Surgical Oncology, Department of Surgery, Oregon Health & Science University, Portland, OR. Electronic address: pommierr@ohsu.edu. ·Surgery · Pubmed #29422353.

ABSTRACT: -- No abstract --

145 Editorial Concise Commentary: Presurgical Evaluation of IPMNs-Eight Is Enough. 2018

Zyromski, Nicholas J. ·Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA. nzyromsk@iupui.edu. ·Dig Dis Sci · Pubmed #29417329.

ABSTRACT: -- No abstract --

146 Editorial Emerging facets in the treatment of patients with hepatopancreaticobiliary malignancies. 2018

McNamara, Mairéad G. ·Department of Medical Oncology, The Christie NHS Foundation Trust, University of Manchester, Withington, Manchester, UK. Electronic address: Mairead.McNamara@christie.nhs.uk. ·Curr Probl Cancer · Pubmed #29397186.

ABSTRACT: -- No abstract --

147 Editorial "International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017": Will this pull us up out of the quagmire of confusing definitions and criteria? 2018

Takaori, Kyoichi. · ·Pancreatology · Pubmed #29389525.

ABSTRACT: -- No abstract --

148 Editorial Intraductal Papillary Mucinous Neoplasm as the Focus for Early Detection of Pancreatic Cancer. 2018

Tanaka, Masao. ·Department of Surgery, Shimonoseki City Hospital, Shimonoseki, Japan. Electronic address: masaotan@med.kyushu-u.ac.jp. ·Gastroenterology · Pubmed #29337154.

ABSTRACT: -- No abstract --

149 Editorial [Quality indicators with reference values and threshold limits in general and visceral surgery : For obesity and metabolic, pancreatic, colon carcinoma and rectal carcinoma surgery]. 2018

Buhr, H J / Hardt, J / Klinger, C / Seyfried, F / Wiegering, A / Dietrich, A / Bartsch, D K / Lorenz, D / Post, S / Germer, C T / Keck, T / Wellner, U. ·Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie, Haus der Bundespressekonferenz, Schiffbauerdamm 40, 10117, Berlin, Deutschland. hbuhr@dgav.de. · Chirurgische Klinik, Universitätsmedizin Mannheim, Mannheim, Deutschland. · Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie, Haus der Bundespressekonferenz, Schiffbauerdamm 40, 10117, Berlin, Deutschland. · Klinik für Allgemein‑, Viszeral‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Würzburg, Deutschland. · Klinik und Poliklinik für Viszeral‑, Transplantations‑, Thorax- und Gefäßchirurgie Bereich Bariatrische Chirurgie, Universitätsklinikum Leipzig, Leipzig, Deutschland. · Klinik für Visceral‑, Thorax- und Gefäßchirurgie, Universitätsklinikum Marburg, Marburg, Deutschland. · Klinik für Allgemein- und Viszeralchirurgie bzw. der Medizinischen Klinik II Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Sana Klinikum Offenbach, Offenbach, Deutschland. · Klinik für Allgemeine Chirurgie, Universitätsklinikum S.-H. Campus Lübeck, Lübeck, Deutschland. ·Chirurg · Pubmed #29330678.

ABSTRACT: -- No abstract --

150 Editorial Benign Tumors of the Pancreas-Radical Surgery Versus Parenchyma-Sparing Local Resection-the Challenge Facing Surgeons. 2018

Beger, Hans G. ·Department of General and Visceral Surgery, University of Ulm, c/o Universitätsklinikum Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. hans@beger-ulm.de. · Department of Oncology, Endocrinology and Minimal-Invasive Surgery, Donau-Klinikum, 89231, Neu-Ulm, Germany. hans@beger-ulm.de. ·J Gastrointest Surg · Pubmed #29299757.

ABSTRACT: Pancreaticoduodenectomy and left-sided pancreatectomy are the surgical treatment standards for tumors of the pancreas. Surgeons, who are requested to treat patients with benign tumors, using standard oncological resections, face the challenge of sacrificing pancreatic and extra-pancreatic tissue. Tumor enucleation, pancreatic middle segment resection and local, duodenum-preserving pancreatic head resections are surgical procedures increasingly used as alternative treatment modalities compared to classical pancreatic resections. Use of local resection procedures for cystic neoplasms and neuro-endocrine tumors of the pancreas (panNETs) is associated with an improvement of procedure-related morbidity, when compared to classical Whipple OP (PD) and left-sided pancreatectomy (LP). The procedure-related advantages are a 90-day mortality below 1% and a low level of POPF B+C rates. Most importantly, the long-term benefits of the use of local surgical procedures are the preservation of the endocrine and exocrine pancreatic functions. PD performed for benign tumors on preoperative normo-glycemic patients is followed by the postoperative development of new onset of diabetes mellitus (NODM) in 4 to 24% of patients, measured by fasting blood glucose and/or oral/intravenous glucose tolerance test, according to the criteria of the international consensus guidelines. Persistence of new diabetes mellitus during the long-term follow-up after PD for benign tumors is observed in 14.5% of cases and after surgery for malignant tumors in 15.5%. Pancreatic exocrine insufficiency after PD is found in the long-term follow-up for benign tumors in 25% and for malignant tumors in 49%. Following LP, 14-31% of patients experience postoperatively NODM; many of the patients subsequently change to insulin-dependent diabetes mellitus (IDDM). The decision-making for cystic neoplasms and panNETs of the pancreas should be guided by the low surgical risk and the preservation of pancreatic metabolic functions when undergoing a limited, local, tissue-sparing procedure.

Back · Next